Security
Enlivex Ltd. Ordinary Shares · ENLV
ENLVNASDAQCommon stockCurrentCIK 1596812Updated Nov 19, 2026
ENLV price & chart
Loading TradingView…
NASDAQ:ENLV on TradingView ↗About the company
Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra™, an advanced clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis. In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem.
In the news
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| AssetsUSD | 22,598,000Source | 31,902,000Source | 53,028,000Source | 77,341,000Source | 95,187,000Source | 35,437,000Source | 2,326,998,000Source | 27,687,000Source | 36,831,000Source | 67,642,000Source |
| Property, Plant and Equipment, NetUSD | 490,000Source | 1,158,000Source | 9,574,000Source | 6,517,000Source | 1,694,000Source | 696,000Source | 361,000Source | 625,000Source | 1,539,000Source | 9,875,000Source |
| Current assets: | ||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,892,000Source | 3,747,000Source | 3,458,000Source | 20,151,000Source | 12,612,000Source | 10,163,000Source | 1,894,000Source | 3,301,000Source | 813,000Source | 49,945,000Source |
| Assets, CurrentUSD | 21,324,000Source | 28,570,000Source | 30,785,000Source | 65,051,000Source | 92,828,000Source | 34,334,000Source | 1,743,178,000Source | 25,993,000Source | 33,764,000Source | 52,330,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,811,000Source | 2,400,000Source | 113,000Source | — | — | — | 4,361,000Source | 2,299,000Source | 1,336,000Source | 2,086,000Source |
| Operating Lease, Right-of-Use AssetUSD | 433,000Source | 870,000Source | 4,734,000Source | 5,369,000Source | 571,000Source | — | 577,000Source | 528,000Source | 1,041,000Source | — |
| Other Assets, NoncurrentUSD | 784,000Source | 1,276,000Source | — | — | — | — | 951,000Source | 1,069,000Source | 1,528,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||
| LiabilitiesUSD | 3,544,000Source | 3,340,000Source | 8,693,000Source | 8,855,000Source | 4,981,000Source | 5,245,000Source | 392,050,000Source | 4,098,000Source | 6,747,000Source | 10,801,000Source |
| Stockholders’ equity: | ||||||||||
| Common Stock, Value, IssuedUSD | 2,708,000Source | 2,385,000Source | 2,136,000Source | 2,113,000Source | 2,104,000Source | 1,513,000Source | 28,730,000Source | 2,685,000Source | 2,137,000Source | 2,117,000Source |
| Additional Paid in CapitalUSD | 147,672,000Source | — | 138,133,000Source | 135,375,000Source | 131,663,000Source | 59,615,000Source | 796,696,000Source | 146,910,000Source | 138,939,000Source | 136,648,000Source |
| Retained Earnings (Accumulated Deficit)USD | -132,427,000Source | -119,329,000Source | -97,035,000Source | -70,103,000Source | -43,805,000Source | -29,508,000Source | 1,108,421,000Source | -127,107,000Source | -112,093,000Source | -83,025,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | — | — | — | 1,101,000Source | 1,101,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 19,054,000Source | 28,562,000Source | 44,335,000Source | 68,486,000Source | 90,206,000Source | 30,192,000Source | 1,934,948,000Source | 23,589,000Source | 30,084,000Source | 56,841,000Source |
| Liabilities and EquityUSD | 22,598,000Source | 31,902,000Source | 53,028,000Source | 77,341,000Source | 95,187,000Source | 35,437,000Source | 2,326,998,000Source | 27,687,000Source | 36,831,000Source | 67,642,000Source |
| Current liabilities: | ||||||||||
| Liabilities, CurrentUSD | 3,328,000Source | 2,841,000Source | 4,991,000Source | 4,213,000Source | 4,576,000Source | 5,009,000Source | 9,021,000Source | 3,799,000Source | 6,061,000Source | 6,607,000Source |
| Operating Lease, Liability, CurrentUSD | 264,000Source | 336,000Source | — | — | — | — | — | 235,000Source | 346,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 216,000Source | 499,000Source | 3,702,000Source | 4,642,000Source | 405,000Source | 236,000Source | 383,000Source | 299,000Source | 686,000Source | — |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | — | — | — | 382,646,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | 216,000Source | 499,000Source | — | — | — | — | — | 299,000Source | 686,000Source | — |
| Additional Financial Items | ||||||||||
| Accrued Liabilities, CurrentUSD | 2,786,000Source | — | — | — | — | — | 5,213,000Source | 2,846,000Source | 4,001,000Source | — |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | 382,646,000Source | — | — | — |
| Additional Paid in Capital, Common Stock | — | —Source | — | — | — | — | — | — | — | — |
| Accounts Payable, Current | — | —Source | — | — | — | — | — | — | — | — |
| Long-term Debt | — | — | —Source | — | — | — | — | — | — | — |
| Short-term Investments | — | — | —Source | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 511,000Source | 697,000Source | 652,000Source | 188,000Source | 131,000Source | 1,783,000Source | 2,065,000Source | 1,951,000Source | 2,712,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | 382,646,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | — | -10,416,000Source | -13,008,000Source | -23,523,000Source | -23,953,000Source |
| Cash flows from investing activities: | |||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | -1,323,000Source | 9,059,000Source | -25,968,000Source | 62,524,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 68,000Source | 103,000Source | 236,000Source | 8,122,000Source |
| Cash flows from financing activities: | |||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | 10,381,000Source | 6,454,000Source | 360,000Source | 150,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,348,000Source | 4,166,000Source | 3,862,000Source | 20,550,000Source | 13,583,000Source | 12,892,000Source | 16,105,000Source | 2,373,000Source | 3,731,000Source | 1,226,000Source | 50,357,000Source |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 1,141,000Source | 1,475,000Source | 1,565,000Source | — |
| Additional Financial Items | |||||||||||
| Share-based Payment Arrangement, ExpenseUSD | 295,000Source | 388,000Source | 511,000Source | — | — | — | — | 1,783,000Source | 2,065,000Source | 1,951,000Source | — |
| DepreciationUSD | 85,000Source | 160,000Source | — | 176,000Source | 122,000Source | 60,000Source | 92,000Source | 332,000Source | 545,000Source | 835,000Source | 777,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | 1,268,084,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | — | — | — | — | 1,149,000Source | -182,000Source | -1,224,000Source | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | 363,191,000Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | 310,124,000Source | — | — | — |
| Gain (Loss) on Disposition of Other AssetsUSD | — | — | — | — | — | — | — | -29,000Source | -957,000Source | -4,244,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | 1,000Source | 82,000Source | 20,000Source | — |
| General and Administrative ExpenseUSD | 937,000Source | 987,000Source | 1,614,000Source | 1,761,000Source | 1,269,000Source | 976,000Source | 601,000Source | 5,796,000Source | 4,913,000Source | 6,139,000Source | 7,104,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | -1,235,528,000Source | 15,014,000Source | 29,068,000Source | 31,060,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | 382,646,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | 792,000Source | 1,069,000Source | 1,565,000Source | 835,000Source |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | -1,983,000Source |
| Net Income (Loss) Attributable to ParentUSD | -1,868,000Source | -3,096,000Source | -6,792,000Source | -9,913,000Source | -3,108,000Source | -3,041,000Source | -1,461,000Source | 1,235,528,000Source | -15,014,000Source | -29,068,000Source | -31,060,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | 31,060,000Source |
| Nonoperating Income (Expense)USD | 1,210,000Source | -110,000Source | — | — | — | — | — | 1,928,000Source | — | — | — |
| Operating ExpensesUSD | 3,078,000Source | 2,986,000Source | 6,649,000Source | 5,871,000Source | 3,808,000Source | 2,233,000Source | 1,297,000Source | 15,029,000Source | 15,888,000Source | 29,395,000Source | 25,797,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | 316,000Source | 324,000Source | 863,000Source | 1,037,000Source |
| Other Nonoperating Income (Expense)USD | — | -110,000Source | -143,000Source | -4,042,000Source | 700,000Source | -808,000Source | — | 1,928,000Source | 874,000Source | 327,000Source | -5,263,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | 513,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | 150,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | 363,191,000Source | — | — | — |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Depreciation, Depletion and Amortization | — | — | — | — | —Source | —Source | — | — | — | — | — |
| Debt and Equity Securities, Realized Gain (Loss) | — | — | —Source | —Source | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | -3,078,000Source | -2,986,000Source | -6,649,000Source | -5,871,000Source | -3,808,000Source | -2,233,000Source | -1,297,000Source | -15,029,000Source | -15,888,000Source | -29,395,000Source | -25,797,000Source |
| Other Nonoperating Income (Expense)USD | — | -110,000Source | -143,000Source | -4,042,000Source | 700,000Source | -808,000Source | — | 1,928,000Source | 874,000Source | 327,000Source | -5,263,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | 1,618,174,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | 382,646,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -1,868,000Source | -3,096,000Source | -6,792,000Source | -9,913,000Source | -3,108,000Source | -3,041,000Source | -1,461,000Source | 1,235,528,000Source | -15,014,000Source | -29,068,000Source | -31,060,000Source |
| Earnings Per Share, BasicUSD per share | -0.08Source | -0.16Source | -0.37Source | -0.54Source | -0.17Source | — | — | 27.04Source | -0.73Source | -1.56Source | -1.69Source |
| Earnings Per Share, DilutedUSD per share | -0.08Source | -0.16Source | -0.37Source | -0.54Source | -0.17Source | — | — | 25.48Source | -0.73Source | -1.56Source | -1.69Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 23,855,663Source | 19,545,056Source | 18,584,801Source | 18,375,206Source | 18,305,882Source | — | — | 45,696,208Source | 20,513,992Source | 18,574,484Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 23,855,663Source | 19,545,056Source | — | — | — | — | — | 48,498,891Source | 20,513,992Source | 18,574,484Source | — |
| Additional Financial Items | |||||||||||
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | 1,268,084,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | — | — | — | — | 1,149,000Source | -182,000Source | -1,224,000Source | — |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | 310,124,000Source | — | — | — |
| General and Administrative ExpenseUSD | 937,000Source | 987,000Source | 1,614,000Source | 1,761,000Source | 1,269,000Source | 976,000Source | 601,000Source | 5,796,000Source | 4,913,000Source | 6,139,000Source | 7,104,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | -1,235,528,000Source | 15,014,000Source | 29,068,000Source | 31,060,000Source |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | 792,000Source | 1,069,000Source | 1,565,000Source | 835,000Source |
| Labor and Related ExpenseUSD | — | — | — | — | — | — | — | 859,000Source | 831,000Source | 912,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | 31,060,000Source |
| Nonoperating Income (Expense)USD | 1,210,000Source | -110,000Source | — | — | — | — | — | 1,928,000Source | — | — | — |
| Operating ExpensesUSD | 3,078,000Source | 2,986,000Source | 6,649,000Source | 5,871,000Source | 3,808,000Source | 2,233,000Source | 1,297,000Source | 15,029,000Source | 15,888,000Source | 29,395,000Source | 25,797,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | 316,000Source | 324,000Source | 863,000Source | 1,037,000Source |
| Other ExpensesUSD | — | — | — | — | — | — | — | 29,000Source | 352,000Source | — | 707,000Source |
| Other General and Administrative ExpenseUSD | — | — | — | — | — | — | — | 186,000Source | 232,000Source | 471,000Source | — |
| Research and Development ExpenseUSD | 2,141,000Source | 1,999,000Source | 5,035,000Source | 4,110,000Source | 2,539,000Source | 1,257,000Source | 696,000Source | 9,204,000Source | 10,623,000Source | 19,012,000Source | 18,693,000Source |
| Debt and Equity Securities, Realized Gain (Loss) | — | — | —Source | —Source | — | — | — | — | — | — | — |
Offerings
Registration 333-298071
Registration 333-295215
Filing attachments
ea031188401ex99-1.htm · 6-K · 2026-11-18
Exhibit 99.1 Enlivex Announces Positive Interim DSMB Safety Review, Supporting Continued Enrollment in Phase IIb Knee Osteoarthritis Trial Nes-Ziona, Israel, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) (“Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company’s randomized, double-blind, placebo-controlled Phase IIb trial evaluating Allo…
Read attachment ↗ea031260501ex4-1.htm · 6-K · 2026-11-17
Exhibit 4.1 ORDINARY SHARE PURCHASE WARRANT Enlivex Ltd. Warrant Shares: Issue Date: November 17, 2026 ────────────────────────────────────────────────────── THIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or…
Read attachment ↗ea031260501ex4-2.htm · 6-K · 2026-11-17
Exhibit 4.2 PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT Enlivex Ltd. Warrant Shares: Issue Date: [●], 2026 THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “T…
Read attachment ↗ea031082401ex99-1.htm · 6-K · 2026-11-17
Exhibit 99.1 ENLIVEX LTD. NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To be held on December 4, 2026 Dear Shareholder: We cordially invite you to attend an Extraordinary General Meeting of Shareholders (the “Meeting”) of Enlivex Ltd. (the “Company”) to be held on Friday, December 4, 2026, at 10:00 a.m. (Israel time), at the offices of the Company at 14 Einstein Street, Ness Ziona, Israel 7403618. The purpose of the Meeting is to vote on a proposal to approve an increase in the …
Read attachment ↗ea031082401ex99-2.htm · 6-K · 2026-11-17
Exhibit 99.2 THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS DIRECTED HEREIN. EXCEPT AS MENTIONED OTHERWISE IN THE PROXY STATEMENT AND BELOW ON THIS PROXY, IF NO DIRECTION IS INDICATED, THIS PROXY WILL BE VOTED “FOR” THE PROPOSAL HEREIN. ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Please mark your vote as in this example PROPOSAL …
Read attachment ↗ea031165001ex99-1.htm · 6-K · 2026-11-16
Exhibit 99.1 Enlivex Announces Pricing of $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Nes-Ziona, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that it has entered into a securities purchase agreement with certain investors for the purchase and sale, in a registered direct offering, of an aggregate of $7,500,000 of the Com…
Read attachment ↗